CVS Group plc

As of December 31, 2025, CVS Group plc carries a market capitalization of 90.79B, placing it among publicly traded companies globally. Its enterprise value stands at 117.29B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

CVS Group plc's next confirmed earnings release is scheduled for March 4, 2027.

As of December 31, 2025, CVS Group plc has 70.71M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, CVS Group plc maintains a current ratio of 1.07, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, CVS Group plc's stock has declined approximately 8.13% over the past 52 weeks. The 50-day moving average sits at 1,267.24, while the 200-day moving average is 1,253.83.

As of December 31, 2025, CVS Group plc holds 1.23B in cash and equivalents against 27.25B in total debt, resulting in a net debt position of 15.83B. Total book value stands at 29.51B, with working capital of 850.00M providing operational flexibility.